• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence to editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".

作者信息

Kim Hee Yeon, Choi Miyoung, Jun Dae Won

机构信息

Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Division of Health Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency (NECA), Seoul, Korea.

出版信息

Clin Mol Hepatol. 2025 Jan;31(1):e48-e51. doi: 10.3350/cmh.2024.0777. Epub 2024 Sep 11.

DOI:10.3350/cmh.2024.0777
PMID:39257208
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11791566/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/11791566/7f48dba4b80e/cmh-2024-0777f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/11791566/7f48dba4b80e/cmh-2024-0777f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/11791566/7f48dba4b80e/cmh-2024-0777f1.jpg

相似文献

1
Correspondence to editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".致关于“普通人群中具有临床意义的肝纤维化患病率：一项系统评价和荟萃分析”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e48-e51. doi: 10.3350/cmh.2024.0777. Epub 2024 Sep 11.
2
Correspondence to letter to the editor on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".致编辑的信，主题为“普通人群中具有临床意义的肝纤维化患病率：一项系统评价和荟萃分析”。
Clin Mol Hepatol. 2025 Jan;31(1):e105-e107. doi: 10.3350/cmh.2024.0937. Epub 2024 Nov 4.
3
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.一般人群中临床显著肝纤维化的患病率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30.
4
Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".在普通人群中发现未诊断出的显著肝纤维化：对后续临床护理的影响：关于“普通人群中临床显著肝纤维化的患病率：系统评价和荟萃分析”的社论
Clin Mol Hepatol. 2025 Jan;31(1):256-260. doi: 10.3350/cmh.2024.0737. Epub 2024 Sep 3.
5
Correspondence to editorial on "Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis".致关于“振动控制瞬时弹性成像和磁共振弹性成像在诊断非酒精性脂肪性肝病患者晚期肝纤维化中的最佳截断值：一项系统评价和荟萃分析”的社论的信函
Clin Mol Hepatol. 2025 Jan;31(1):e52-e54. doi: 10.3350/cmh.2024.0815. Epub 2024 Sep 24.
6
Global Prevalence of Advanced Liver Fibrosis and Cirrhosis in the General Population: A Systematic Review and Meta-analysis.普通人群中晚期肝纤维化和肝硬化的全球患病率：一项系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2025 Jun;23(7):1123-1134. doi: 10.1016/j.cgh.2024.08.020. Epub 2024 Aug 30.
7
The prevalence of nonalcoholic fatty liver disease in people living with HIV: a systematic review and meta-analysis.艾滋病毒感染者中非酒精性脂肪性肝病的患病率：一项系统评价和荟萃分析。
BMC Infect Dis. 2025 Feb 19;25(1):239. doi: 10.1186/s12879-025-10455-y.
8
Correspondence to editorial on "Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis".致关于“振动控制瞬时弹性成像和磁共振弹性成像在诊断非酒精性脂肪性肝病患者晚期肝纤维化中的最佳截断值：一项系统评价和荟萃分析”的社论的信函。
Clin Mol Hepatol. 2025 Jan;31(1):e61-e63. doi: 10.3350/cmh.2024.0878. Epub 2024 Oct 15.
9
Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.一般人群中用非侵入性肝纤维化标志物定义的临床显著肝脏疾病的流行情况：系统评价。
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):288-297. doi: 10.1016/S2468-1253(16)30205-9. Epub 2017 Feb 1.
10
Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on "Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis".评估代谢功能障碍相关脂肪性肝病中晚期纤维化的重要工具：关于“振动控制瞬时弹性成像和磁共振弹性成像诊断非酒精性脂肪性肝病患者晚期肝纤维化的最佳截断值：一项系统评价和荟萃分析”的社论
Clin Mol Hepatol. 2025 Jan;31(1):277-280. doi: 10.3350/cmh.2024.0823. Epub 2024 Oct 11.

本文引用的文献

1
Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".在普通人群中发现未诊断出的显著肝纤维化：对后续临床护理的影响：关于“普通人群中临床显著肝纤维化的患病率：系统评价和荟萃分析”的社论
Clin Mol Hepatol. 2025 Jan;31(1):256-260. doi: 10.3350/cmh.2024.0737. Epub 2024 Sep 3.
2
Population screening for cirrhosis.人群中肝硬化的筛查。
Hepatol Commun. 2024 Aug 26;8(9). doi: 10.1097/HC9.0000000000000512. eCollection 2024 Sep 1.
3
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.
KASL慢性肝病肝纤维化评估无创检测临床实践指南。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.
4
Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis.一般人群中临床显著肝纤维化的患病率：系统评价和荟萃分析。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S199-S213. doi: 10.3350/cmh.2024.0351. Epub 2024 Jul 30.
5
Implementation of a liver health check in people with type 2 diabetes.对2型糖尿病患者进行肝脏健康检查
Lancet Gastroenterol Hepatol. 2024 Jan;9(1):83-91. doi: 10.1016/S2468-1253(23)00270-4.
6
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial.通过自动化纤维化评分计算和电子提醒信息检测 2 型糖尿病患者的晚期肝病的临床护理路径：一项随机对照试验。
Gut. 2023 Nov 24;72(12):2364-2371. doi: 10.1136/gutjnl-2023-330269.
7
The Global Burden of Liver Disease.《全球肝脏疾病负担》
Clin Gastroenterol Hepatol. 2023 Jul;21(8):1978-1991. doi: 10.1016/j.cgh.2023.04.015. Epub 2023 Apr 28.
8
Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence.在不同类型的系统评价中进行比例荟萃分析：证据综合者的指南。
BMC Med Res Methodol. 2021 Sep 20;21(1):189. doi: 10.1186/s12874-021-01381-z.
9
The Development and Implementation of a Commissioned Pathway for the Identification and Stratification of Liver Disease in the Community.社区肝病识别与分层委托路径的制定与实施
Frontline Gastroenterol. 2020 Feb 10;11(2):86-92. doi: 10.1136/flgastro-2019-101177. Epub 2019 Jun 26.
10
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究：1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担：系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.